Drawing on extensive drug discovery expertise, we design comprehensive gene-to-structure pipelines that encompass clone selection, protein expression, crystallization/grid freezing, X-ray diffraction or cryo-EM data acquisition, and high-resolution structure refinement—delivering robust and reproducible results.
We provide end-to-end management of both in-house and outsourced gene-to-structure programs, serving as the central point of contact between project teams and CRO partners. Our team ensures seamless coordination, expert troubleshooting at every stage, and hands-on refinement of structural solutions to consistently deliver high-quality results.
We specialize in generating, solving, and refining X-ray crystallography and cryo-EM data, with a clear focus on communicating key structural insights that address project team objectives. By providing hands-on structure refinement and analysis, we minimize external exposure of experimental conditions and protect critical IP. Our fractional FTE model provides efficient, flexible, and cost-effective access to specialized expertise exactly when you need it.
Designed and built advanced in-house structural biology platforms for companies at both startup and large scale.
